Search by Drug Name or NDC

    NDC 13668-0141-90 Clopidogrel Bisulfate 75 mg/1 Details

    Clopidogrel Bisulfate 75 mg/1

    Clopidogrel Bisulfate is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Torrent Pharmaceuticals Limited. The primary component is CLOPIDOGREL BISULFATE.

    Product Information

    NDC 13668-0141
    Product ID 13668-141_9861b1f3-7fc7-42fa-9e5e-db53e5bc1c4c
    Associated GPIs 85158020100320
    GCN Sequence Number 038164
    GCN Sequence Number Description clopidogrel bisulfate TABLET 75 MG ORAL
    HIC3 M9P
    HIC3 Description PLATELET AGGREGATION INHIBITORS
    GCN 96010
    HICL Sequence Number 017539
    HICL Sequence Number Description CLOPIDOGREL BISULFATE
    Brand/Generic Generic
    Proprietary Name Clopidogrel Bisulfate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Clopidogrel Bisulfate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 75
    Active Ingredient Units mg/1
    Substance Name CLOPIDOGREL BISULFATE
    Labeler Name Torrent Pharmaceuticals Limited
    Pharmaceutical Class Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA090844
    Listing Certified Through 2024-12-31

    Package

    NDC 13668-0141-90 (13668014190)

    NDC Package Code 13668-141-90
    Billing NDC 13668014190
    Package 90 TABLET in 1 BOTTLE (13668-141-90)
    Marketing Start Date 2012-05-17
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.064
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description CLOPIDOGREL 75 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis